rs1801311

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002490.6(NDUFA6):​c.26C>T​(p.Ala9Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.335 in 1,613,960 control chromosomes in the GnomAD database, including 93,601 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11348 hom., cov: 34)
Exomes 𝑓: 0.33 ( 82253 hom. )

Consequence

NDUFA6
NM_002490.6 missense

Scores

1
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.918

Publications

73 publications found
Variant links:
Genes affected
NDUFA6 (HGNC:7690): (NADH:ubiquinone oxidoreductase subunit A6) This gene encodes a member of the LYR family of proteins that contain a highly conserved tripeptide (LYR) motif near the N-terminus. The encoded protein is an accessory subunit of NADH: ubiquinone oxidorerductase (Complex I), which is the largest enzyme of the mitochondrial membrane respiratory chain. Complex I functions in electron transfer from NADH to the respiratory chain. [provided by RefSeq, Oct 2016]
NDUFA6-DT (HGNC:45273): (NDUFA6 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.8364191E-4).
BP6
Variant 22-42090719-G-A is Benign according to our data. Variant chr22-42090719-G-A is described in ClinVar as Benign. ClinVar VariationId is 1244198.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.491 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFA6NM_002490.6 linkc.26C>T p.Ala9Val missense_variant Exon 1 of 3 ENST00000498737.8 NP_002481.3 P56556A0A2Y9D025
NDUFA6-DTNR_034118.2 linkn.-214G>A upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFA6ENST00000498737.8 linkc.26C>T p.Ala9Val missense_variant Exon 1 of 3 1 NM_002490.6 ENSP00000418842.3 P56556

Frequencies

GnomAD3 genomes
AF:
0.376
AC:
57170
AN:
152038
Hom.:
11312
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.496
Gnomad AMI
AF:
0.216
Gnomad AMR
AF:
0.332
Gnomad ASJ
AF:
0.391
Gnomad EAS
AF:
0.151
Gnomad SAS
AF:
0.381
Gnomad FIN
AF:
0.383
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.329
Gnomad OTH
AF:
0.377
GnomAD2 exomes
AF:
0.333
AC:
83712
AN:
251308
AF XY:
0.337
show subpopulations
Gnomad AFR exome
AF:
0.504
Gnomad AMR exome
AF:
0.267
Gnomad ASJ exome
AF:
0.402
Gnomad EAS exome
AF:
0.144
Gnomad FIN exome
AF:
0.388
Gnomad NFE exome
AF:
0.330
Gnomad OTH exome
AF:
0.351
GnomAD4 exome
AF:
0.331
AC:
483755
AN:
1461804
Hom.:
82253
Cov.:
58
AF XY:
0.333
AC XY:
242391
AN XY:
727208
show subpopulations
African (AFR)
AF:
0.511
AC:
17106
AN:
33480
American (AMR)
AF:
0.282
AC:
12592
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.403
AC:
10541
AN:
26134
East Asian (EAS)
AF:
0.153
AC:
6078
AN:
39700
South Asian (SAS)
AF:
0.380
AC:
32785
AN:
86258
European-Finnish (FIN)
AF:
0.378
AC:
20151
AN:
53348
Middle Eastern (MID)
AF:
0.422
AC:
2433
AN:
5768
European-Non Finnish (NFE)
AF:
0.325
AC:
361057
AN:
1111996
Other (OTH)
AF:
0.348
AC:
21012
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
23416
46831
70247
93662
117078
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11730
23460
35190
46920
58650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.376
AC:
57256
AN:
152156
Hom.:
11348
Cov.:
34
AF XY:
0.378
AC XY:
28094
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.497
AC:
20620
AN:
41498
American (AMR)
AF:
0.332
AC:
5081
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.391
AC:
1356
AN:
3468
East Asian (EAS)
AF:
0.150
AC:
774
AN:
5166
South Asian (SAS)
AF:
0.382
AC:
1845
AN:
4832
European-Finnish (FIN)
AF:
0.383
AC:
4049
AN:
10580
Middle Eastern (MID)
AF:
0.503
AC:
147
AN:
292
European-Non Finnish (NFE)
AF:
0.329
AC:
22395
AN:
67994
Other (OTH)
AF:
0.375
AC:
792
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1876
3753
5629
7506
9382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.346
Hom.:
30111
Bravo
AF:
0.374
TwinsUK
AF:
0.316
AC:
1171
ALSPAC
AF:
0.316
AC:
1219
ESP6500AA
AF:
0.493
AC:
2174
ESP6500EA
AF:
0.336
AC:
2889
ExAC
AF:
0.337
AC:
40891
Asia WGS
AF:
0.281
AC:
977
AN:
3478
EpiCase
AF:
0.339
EpiControl
AF:
0.345

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mitochondrial complex I deficiency, nuclear type 33 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

NDUFA6-related disorder Benign:1
Nov 11, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
13
DANN
Uncertain
0.99
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.58
FATHMM_MKL
Benign
0.46
N
MetaRNN
Benign
0.00018
T;T
MetaSVM
Benign
-0.93
T
PhyloP100
0.92
PrimateAI
Benign
0.35
T
REVEL
Benign
0.094
Sift4G
Benign
0.10
.;T
Vest4
0.13
MPC
0.21
ClinPred
0.053
T
GERP RS
2.4
PromoterAI
-0.12
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.029
gMVP
0.42
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801311; hg19: chr22-42486723; COSMIC: COSV68911946; COSMIC: COSV68911946; API